slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 90,151-90,180
Pages 3,225
Rows per page 30
Component
90,151-90,180 of 96,741
11
The slide uses a visual 'X' to indicate the lack of efficacy for amplifications across multiple drug classes.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide uses a color-coded matrix to illustrate clinical failure or limited efficacy in amplified tumors.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
The slide uses a combination of microscopy images, a circular genomic plot (circos plot), and a diagram of cell division to illustrate the mechanism.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
16
Data source: Kim, Nguyen, Turner, et al. 2020 Nature Genetics. Analysis of WGS data from >3,000 tumor and matched normal samples.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
18
The slide uses a before-and-after experimental setup with microscopy images and longitudinal data plots to illustrate therapeutic resistance.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
26
The slide uses a comparative visual framework to contrast normal vs. stressed replication mechanisms.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
27
The slide uses a combination of a CRISPR screen scatter plot and a biological process diagram to illustrate the mechanism.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
30
Includes a mechanism of action diagram illustrating 'Therapy Enhanced Synthetic Lethality'.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
31
Shows synergistic effect of BBI-355 with Palbociclib and Erlotinib.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
39
The slide uses a biological mechanism diagram to explain the therapeutic rationale for BBI-825.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
44
The slide uses a diagram to link specific cancer types and mutations to resistance mechanisms, ultimately pointing to BBI-825 as the solution.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Market Size1 hit
47
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Loop · Golden Circle1 hit
48
The slide uses a timeline-style progression to frame the company's technology as the next logical evolution in cancer treatment.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Why NowLoop · Why Now1 hit
08
The chart uses a Gantt-style visualization to represent clinical trial phases for different indications.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
11
The slide features a stylized 3D rendering of a cell, likely representing the therapeutic target or mechanism of action.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The slide uses a comparison table to contrast clinical trial data for CRG-022 against historical benchmarks for ZUMA-1, JULIET, and TRANSCEND.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
22
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
14
The slide highlights the regulatory environment as a key driver for development, citing specific FDA definitions and successful approvals.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
40
The slide uses a split-screen layout to frame the problem from two angles: supply-side shortage and clinical-side risk.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
45
The slide uses a structured table format to categorize achievements into three pillars: Clinical, Corporate, and Financing.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
08
Includes aerial photography of the facility site.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations 1 hit
12
The slide uses a combination of a bar chart for historical growth and a conceptual framework to contrast current focus (small baskets) with future opportunity (mid-sized baskets).Deliveroo | Results Presentation Deck | 32 slides · Deliveroo
Conference presentation Investor relations Beat · Satisfaction1 hit
02
Uses a 'villain' framing to discredit the activist investor.Disney | Shareholder Engagement Presentation Deck | 20 slides · Disney
Activist deck Investor relations Beat · Situation & Context1 hit
10
Uses external media quotes to validate the claim of a personal vendetta.Disney | Shareholder Engagement Presentation Deck | 20 slides · Disney
Activist deck Investor relations Beat · Evidence & Proof1 hit
14
The slide uses a 'preempt_rebuttal' strategy by explaining why other companies (Big Tech, Comcast, Netflix) were excluded from the peer group.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
23
Includes a quote preempting activist criticism by suggesting management was already executing on cost cuts.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
29
Uses external testimonials to validate the 'seamless' nature of the transitions.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Solution (Provide relief)1 hit
36
Uses a mix of big numbers, comparison, and a pie chart to discredit the activist's claims.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Solution (Provide relief)1 hit
41
Uses a 'villain' framing for Jay Rasulo by linking his criticism to his poor track record at iHeartMedia.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Solution (Provide relief)1 hit
56
Features the original 1957 Walt Disney Synergy Map as evidence of the company's long-standing integrated strategy.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Solution (Provide relief)1 hit